2020 GLOBAL FINALIST
Lucence
Digital Health Covid-19 Female Founder
Most cancers are currently detected in the late stages which results in poor treatment outcomes. Lucence’s precision medical-testing technology detects cancer signals in blood more quickly, accurately and cost-effectively. It’s time to end avoidable deaths caused by cancer.
💸 Select investors: IHH Healthcare Berhad, Heliconia Capital, SGInnovate, Boon Hwee Koh, Lim Kaling
📌 HQ: Palo Alto, California, United States